CUREPHARMA

Serial Number 79300671
Registration 6648799
404

Registration Progress

Application Filed
Jul 23, 2020
Under Examination
Approved for Publication
Dec 7, 2021
Published for Opposition
Dec 7, 2021
Registered
Feb 22, 2022

Trademark Image

CUREPHARMA

Basic Information

Serial Number
79300671
Registration Number
6648799
Filing Date
July 23, 2020
Registration Date
February 22, 2022
Published for Opposition
December 7, 2021
Cancellation Date
October 3, 2023
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Oct 3, 2023

Rights Holder

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

99
Address
Room 2606, No 763 Mengzi Road,
Huangpu District Shanghai
CN

Ownership History

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

Original Applicant
99
CN

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

Owner at Publication
99
CN

CUREPHARMA (SHANGHAI) BIOTECHNOLOGY CO., LTD.

Original Registrant
99
CN

Legal Representation

Attorney
Alexander Reid

USPTO Deadlines

Next Deadline
921 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-22)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Oct 22, 2023 DENC E NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Loading...
Oct 22, 2023 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Aug 22, 2022 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 27, 2022 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Jul 27, 2022 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
May 22, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 13, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Dec 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 7, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 17, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 17, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 3, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 6, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jun 22, 2021 ATRV O ATTORNEY REVIEW COMPLETED Loading...
May 18, 2021 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
May 16, 2021 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
May 3, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 10, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 10, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 7, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 6, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 30, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 1, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 28, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 24, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Design Mark
The mark consists of the term "CUREPHARMA" above a horizontal DNA helix.